Table: begin end state 1 31 cytoplasmic 32 49 transmembrane 50 60 non-cytoplasmic 61 80 transmembrane 81 111 cytoplasmic 112 137 transmembrane 138 166 non-cytoplasmic 167 186 transmembrane 187 197 cytoplasmic 198 216 transmembrane 217 235 non-cytoplasmic 236 264 transmembrane 265 275 cytoplasmic 276 298 transmembrane 299 324 non-cytoplasmic 325 346 transmembrane 347 366 cytoplasmic 367 389 transmembrane 390 408 non-cytoplasmic 409 426 transmembrane 427 446 cytoplasmic 447 467 transmembrane 468 469 non-cytoplasmic
Input: >GFF3450 FitnessBrowser__psRCH2:GFF3450 MSDKTSLAAGTFAGARARIQDNASRGLWSSRWVFFLAATGSAVGLGNIWKFPYVTGQNGG GAFVLVYLACILLIGIPLLMTEVMIGRRGRANPDGAVARLAREAGASSRWRVVGWLGGLT GFLILSFYLVVAGWALAYVPATFSGGFAGVSGEASGELFGALLADPLRLVVCATLVLAAT MLIVGFGVRGGLERSLRFLMPGLFVLMLVLVVYAAIEGEFAQALQFLFVPDFSALTAQSV LIALGHAFFTLSLGCGAMMVYGSYLPEGTSIAKTSILVALADTAVALLAGLAIFPLVFGN GLEPGAGPGLIFVTLPIAFGQMPLGQVVGGLFFIMLVIAALTSAISLSEPSIAWLTERFR ISRTKAVLGSGLVLWLLSLGSVFSFNHWADYQLFGKTFFDTLDYLTTNWLMPLGGLGTVL FTGWVLQRQVVSEAIGIRNAGLFQAWWNLLRYGTPVAIVLVFLNLLGLI
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server